Keio Innovation Initiative contributed to a $20m round that increased the total funding for medical access app developer CureApp, partially based on Keio University research, to nearly $39m.

Japan-based medical booking app developer CureApp received ¥2.2bn ($20.4m) in funding from investors including Keio Innovation Initiative (KII), the venture fund of Keio University, today. The round also featured diversified trading group Itochu’s corporate venturing unit Itochu Technology Ventures (ITV), insurance provider Dai-ichi Life and property developer Mori Trust. Mizuho Capital, the venture capital arm…

The rest of this content is only accessible to Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.